NO992090L - Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav - Google Patents

Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav

Info

Publication number
NO992090L
NO992090L NO992090A NO992090A NO992090L NO 992090 L NO992090 L NO 992090L NO 992090 A NO992090 A NO 992090A NO 992090 A NO992090 A NO 992090A NO 992090 L NO992090 L NO 992090L
Authority
NO
Norway
Prior art keywords
preparation
hydrophobic
protein conjugate
amino acids
porcine protein
Prior art date
Application number
NO992090A
Other languages
English (en)
Other versions
NO992090D0 (no
Inventor
Angelika Esswein
Kurt Lang
Petra Rueger
Tilmann Seytter
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98107911A external-priority patent/EP0953575A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO992090D0 publication Critical patent/NO992090D0/no
Publication of NO992090L publication Critical patent/NO992090L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Et pinnsvinkonjugat som er karakterisert ved at det inneholder: a) et poly- peptid som består av 10-30 hydrofobe aminosyrer og/eller aminosyrer som danner transmembran-helikser og er positivt ladet, b) 1-4 alifatiske, mettede eller umette- de hydrokarbonrester med en kjedelengde på 10-24 C-atomer og med hydrofob virkning, eller c) en hydrofob tioforbindelse kovalent bundet til et pinnsvinprotein og som har en mangedoblet øket aktivitet og er egnet som farmasøytisk middel, er beskrevet.
NO992090A 1998-04-30 1999-04-29 Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav NO992090L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98107911A EP0953575A1 (de) 1998-04-30 1998-04-30 Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
EP98116733 1998-09-03

Publications (2)

Publication Number Publication Date
NO992090D0 NO992090D0 (no) 1999-04-29
NO992090L true NO992090L (no) 1999-11-01

Family

ID=26149214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992090A NO992090L (no) 1998-04-30 1999-04-29 Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav

Country Status (18)

Country Link
US (4) US6468978B1 (no)
EP (2) EP0953576B1 (no)
JP (1) JP3433136B2 (no)
KR (1) KR19990083621A (no)
CN (1) CN1233616A (no)
AT (1) ATE308563T1 (no)
AU (1) AU719797B2 (no)
CA (1) CA2269221A1 (no)
CY (1) CY1105683T1 (no)
DE (1) DE69928040T2 (no)
DK (1) DK0953576T3 (no)
ES (1) ES2252886T3 (no)
HU (1) HUP9901411A2 (no)
IL (1) IL129620A (no)
MA (1) MA26625A1 (no)
NO (1) NO992090L (no)
NZ (1) NZ335385A (no)
SG (1) SG80028A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136230A0 (en) * 1997-11-28 2001-05-20 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP0953576B1 (en) * 1998-04-30 2005-11-02 Curis, Inc. Active hedgehog protein conjugate, process for its production and use
EP0978285B1 (en) * 1998-08-07 2005-11-23 F. Hoffmann-La Roche Ag Stable pharmaceutical composition of hedgehog proteins and use thereof.
TW570805B (en) * 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
AU763032B2 (en) * 1998-12-03 2003-07-10 Curis, Inc. Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
WO2000073337A1 (en) * 1999-06-01 2000-12-07 Biogen, Inc. Polymer conjugates of hedgehog proteins and uses
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
US7573637B2 (en) * 2004-08-03 2009-08-11 Seiko Epson Corporation Intrinsic polarizer and method of manufacturing an intrinsic polarizer
US8669418B2 (en) * 2005-12-22 2014-03-11 Vib Vzw Means and methods for mediating protein interference
US20100316566A1 (en) * 2008-02-27 2010-12-16 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
WO2010065908A2 (en) * 2008-12-05 2010-06-10 Catchmark Jeffrey M Degradable biomolecule compositions
US20110086236A1 (en) * 2009-10-13 2011-04-14 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
RU2637085C2 (ru) * 2011-06-06 2017-11-29 КИНЕТА УАН, ЭлЭлСи Фармацевтические композиции на основе shk и способы их получения и использования
US10202517B2 (en) 2013-07-26 2019-02-12 The Penn State Research Foundation Polymer compositions and coatings
KR20170065016A (ko) * 2015-12-02 2017-06-12 한미약품 주식회사 지방산 유도체를 이용한 단백질 결합체 및 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
CA2071912C (en) * 1990-11-30 2002-10-15 Hanne Bentz Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
US5789543A (en) * 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
CA2179029C (en) * 1993-12-30 2009-02-24 Philip W. Ingham Vertebrate embryonic pattern-inducing hedgehog-like proteins
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
CA2267106A1 (en) * 1996-10-07 1998-07-16 The Johns Hopkins University School Of Medicine Novel hedgehog-derived polypeptides
IL136230A0 (en) * 1997-11-28 2001-05-20 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
AU757497B2 (en) * 1997-12-03 2003-02-20 Biogen, Inc. Hydrophobically-modified protein compositions and methods
EP0953576B1 (en) * 1998-04-30 2005-11-02 Curis, Inc. Active hedgehog protein conjugate, process for its production and use
EP0978285B1 (en) * 1998-08-07 2005-11-23 F. Hoffmann-La Roche Ag Stable pharmaceutical composition of hedgehog proteins and use thereof.
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro

Also Published As

Publication number Publication date
CA2269221A1 (en) 1999-10-30
AU719797B2 (en) 2000-05-18
JP3433136B2 (ja) 2003-08-04
US7153836B2 (en) 2006-12-26
EP0953576B1 (en) 2005-11-02
US20050148510A1 (en) 2005-07-07
EP1557427A2 (en) 2005-07-27
EP1557427A3 (en) 2005-10-19
CN1233616A (zh) 1999-11-03
JP2000053699A (ja) 2000-02-22
SG80028A1 (en) 2001-04-17
HUP9901411A2 (hu) 1999-12-28
NZ335385A (en) 2000-09-29
NO992090D0 (no) 1999-04-29
US20070191274A1 (en) 2007-08-16
HU9901411D0 (en) 1999-07-28
KR19990083621A (ko) 1999-11-25
ATE308563T1 (de) 2005-11-15
EP0953576A1 (en) 1999-11-03
US6468978B1 (en) 2002-10-22
MA26625A1 (fr) 2004-12-20
US6818623B2 (en) 2004-11-16
DE69928040D1 (de) 2005-12-08
ES2252886T3 (es) 2006-05-16
DE69928040T2 (de) 2006-07-27
IL129620A0 (en) 2000-02-29
AU2500999A (en) 1999-11-11
US20030139574A1 (en) 2003-07-24
DK0953576T3 (da) 2006-03-20
CY1105683T1 (el) 2010-12-22
IL129620A (en) 2009-06-15

Similar Documents

Publication Publication Date Title
NO992090L (no) Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav
Balhorn et al. Mouse sperm chromatin proteins: quantitative isolation and partial characterization
Dolphin et al. Pertussis toxin reverses adenosine inhibition of neuronal glutamate release
Hu et al. An angiogenin-binding protein from endothelial cells.
AU2022201708A1 (en) Compounds and methods for inhibiting phosphate transport
Segui‐Real et al. Functional independence of the protein translocation machineries in mitochondrial outer and inner membranes: passage of preproteins through the intermembrane space.
PT835262E (pt) Metodo para o tratamento de osteopenia induzida por corticosteroides
EP0748817A3 (en) Parathyroid hormone derivatives and their use
Saks et al. Specific inhibition of ATP-ADP translocase in cardiac mitoplasts by antibodies against mitochondrial creatine kinase
Orloff et al. Characterization of canine renal receptors for the parathyroid hormone-like protein associated with humoral hypercalcemia of malignancy
Jensen et al. Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists
Forte et al. Studies of kidney plasma membrane adenosine-3′, 5′-monophosphate-dependent protein kinase
von Stedingk et al. Mitochondrial protein import: modification of sulfhydryl groups of the inner mitochondrial membrane import machinery in Solanum tuberosum inhibits protein import
Tait et al. Artificial low‐molecular‐mass substrates of cholera toxin
CA2010660A1 (en) Osteogenic growth polypeptides identified from regenerating bone marrow
DE10080849D2 (de) Fragmente des Virus Proteins 2 oder 3 des Polymavirus als Fähren für Wirkstoffe
ES2084599T3 (es) Metodo para purificar antitrombina iii y preparacion de antitrombina iii que contiene dicha antitrombina iii.
Meiniel et al. The complex-type glycoprotein secreted by the bovine subcommissural organ: an immunological study using C 1 B 8 A 8 monoclonal antibody
Elhammer et al. Glycosylation of rat liver cytochrome b5 on the ribosomal level
PE20001068A1 (es) Produccion de analogos de tripsinogeno recombinante solubles
DE60034149D1 (de) Hydrophobe aminosäuren enthaltende trockene zusammensetzung
Haeger et al. Diazobenzenesulphonate selectively abolishes stimulation of glucuronidation by UDP-N-acetylglucosamine
Agui et al. Agonist-induced desensitization of the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland
Gaikwad et al. The use of chemical cross-linking to identify proteins that interact with a mitochondrial presequence.
HUP0100132A2 (hu) A béta-lipotropin és felhasználása

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application